Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Deloitte
Cipla
Fuji
AstraZeneca
McKesson
Cerilliant
Moodys

Generated: July 18, 2018

DrugPatentWatch Database Preview

ROPIVACAINE HYDROCHLORIDE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for ropivacaine hydrochloride and what is the scope of ropivacaine hydrochloride patent protection?

Ropivacaine hydrochloride
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Akorn, Akorn Inc, Aurobindo Pharma Ltd, Hospira, Inforlife, Mylan Asi, Navinta Llc, and Somerset Theraps Llc, and is included in nine NDAs. There are four patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Ropivacaine hydrochloride has seventy-four patent family members in twenty countries.

There are thirteen drug master file entries for ropivacaine hydrochloride. Nine suppliers are listed for this compound.
Pharmacology for ROPIVACAINE HYDROCHLORIDE
Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Synonyms for ROPIVACAINE HYDROCHLORIDE
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilid
(-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
(-)-1-Propyl-2',6'-pipecoloxylidide
(-)-Ropivacaine
(2S)-2-[(2,6-dimethylphenyl)carbamoyl]-1-propylpiperidinium chloride
(2S)-2-[(2,6-dimethylphenyl)carbamoyl]-1-propylpiperidinium chloride--water(1/1)
(2S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide hydrochloride monohydrate
(2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide hydrate hydrochloride
(2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide hydrochloride
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrate hydrochloride
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride--water (1/1)
(S)-(--)-1-propyl-2',6'-pipecoloxylidide hydrochloride
(S)-(-)-1-propyl-2',6'-pipecoloxylidide
(S)-(-)-1-propyl-2',6'-pipecoloxylidine hydrochloride monohydrate
(S)-(-)-1-propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)amide hydrochloride monohydrate
(S)-1-propyl-2-piperidylformo-2',6'-xylidide hydrochloride
(S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide
(S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate
(S)-Ropivacaine
(S)-ropivacaine HCl
(S)-Ropivacaine hydrochloride
(S)-ropivacaine hydrochloride (anhydrous)
(S)-ropivacaine hydrochloride hydrate
(S)-ropivacaine hydrochloride monohydrate
(S)-ropivacaine monohydrochloride (anhydrous)
057R954
112R357
132112-35-7
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2S)-
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (S)-(-)-
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, monohydrochloride, (S)-
2-Piperidinecarboxamide,N-(2,6-dimethylphenyl)-1-propyl-, (2S)-
2694AH
35504LBE2T
717R158
7IO5LYA57N
84057-95-4
98717-15-8
A840710
AB0004985
AB00698466_10
AB00698466-07
AB1007072
AC-2101
AC1L41QM
AC1L41QN
AC1OCF17
ACT04747
AJ-24263
AK117722
AK161933
AK326168
AKOS015900322
AKOS015918210
AKOS015950974
AKOS015994752
AKOS017343283
AL-281
AL-381
AN-14289
AN-9624
Anapaine
Anapeine
Anapeine (TN)
API0007295
B3377
BC209065
BIDD:GT0203
C07532
C17H26N2O.ClH
C17H26N2O.HCl
C17H26N2O.HCl.H2O
CAS-98717-15-8
CCG-101108
CHEBI:34954
CHEBI:60803
CHEBI:8890
CHEMBL1077896
CHEMBL1889140
CPD000469137
CS-0013146
CS-2672
D04048
D08490
D09RHQ
DB00296
DR000904
DSSTox_CID_28353
DSSTox_GSID_48379
DSSTox_RID_82753
DTXSID2048379
DTXSID4040187
ETI-211
F-93
FC1264
FT-0631143
FT-0674459
GTPL7602
H838
HE306542
HE395698
HY-B0563A
HY-B0563B
I14-176
I14-8019
K500
KB-60355
KB-60356
KS-5134
L-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide hydrochloride monohydrate
L-N-n-propylpipecolic acid-2,6-xylidide
L-N-n-propylpipecolic acid-2,6-xylidide hydrochloride
L-ropivacaine HCl
L-ropivacaine hydrochloride
L-ropivacaine hydrochloride monohydrate
LEA 103
LS-113954
MFCD00864425
MFCD00946578
MFCD02102164
MLS001401363
MolPort-003-983-292
MolPort-005-935-350
MolPort-006-069-213
N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide; hydron; chloride
Narapin
Narop
Naropeine
Naropin
Naropin (TN)
Naropin hydrochloride monohydrate
Naropina
naropine
NC00358
NCGC00164597-01
NCGC00164597-02
NDNSIBYYUOEUSV-RSAXXLAASA-N
Noropine
PRF-108
Q-100126
Q-201677
Q-201678
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine (hydrochloride monohydrate)
Ropivacaine (INN)
Ropivacaine [INN:BAN]
Ropivacaine [INN]
Ropivacaine base
ROPIVACAINE HCl
Ropivacaine hydrochloride (USP)
Ropivacaine hydrochloride [USP]
Ropivacaine hydrochloride hydrate
Ropivacaine hydrochloride hydrate (JAN)
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
Ropivacaine hydrochloride monohydrate, >=98% (HPLC)
Ropivacaine hydrochloride monohydrate, European Pharmacopoeia (EP) Reference Standard
Ropivacaine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Ropivacaine monohydrochloride
ropivacaine monohydrochloride,
ropivacaine monohydrochloride, (S)-isomer
ropivacaine monohydrochloride, (S)-isomer
Ropivacainehydrochloridehydrate
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
S-Ropivacaine hydrochloride
s4058
SAM001246524
SC-23114
SC-26798
SCHEMBL236432
SCHEMBL33292
SCHEMBL510838
SMR000469137
ST24049128
ST51051452
ST51054447
Tox21_112221
Tox21_112221_1
UNII-35504LBE2T
UNII-7IO5LYA57N
UNII-V910P86109
V910P86109
VSHFRHVKMYGBJL-CKUXDGONSA-N
ZINC897002
ZKMNUMMKYBVTFN-HNNXBMFYSA-N

US Patents and Regulatory Information for ROPIVACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc ROPIVACAINE HYDROCHLORIDE ropivacaine hydrochloride SOLUTION;INJECTION 203955-001 Apr 11, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ROPIVACAINE HYDROCHLORIDE ropivacaine hydrochloride SOLUTION;INJECTION 090194-005 Sep 23, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Inforlife ROPIVACAINE HYDROCHLORIDE ropivacaine hydrochloride SOLUTION;INJECTION 206166-004 Jun 11, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ROPIVACAINE HYDROCHLORIDE ropivacaine hydrochloride SOLUTION;INJECTION 090194-006 Sep 23, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for ROPIVACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fresenius Kabi Usa NAROPIN ropivacaine hydrochloride SOLUTION;INJECTION 020533-005 Sep 24, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa NAROPIN ropivacaine hydrochloride SOLUTION;INJECTION 020533-003 May 1, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa NAROPIN ropivacaine hydrochloride SOLUTION;INJECTION 020533-003 May 1, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa NAROPIN ropivacaine hydrochloride SOLUTION;INJECTION 020533-001 May 1, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for ROPIVACAINE HYDROCHLORIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB96/051 United Kingdom ➤ Try a Free Trial PRODUCT NAME: (S)-(-)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE HYDROCHLORIDE MONOHYDRATE (GENERIC NAME: ROPIVACAINE MONOHYDROCHLORIDE MONOHYDRATE); REGISTERED: SE 12319 19950915; SE 12322 19950915; SE 12323 19950915; UK 0017/0375 19960517; UK 0017/0376 19960517; UK 0017/0377 19960517; UK 0017/0378 19960517
C0042 Belgium ➤ Try a Free Trial PRODUCT NAME: CHLORHYDRATE DE ROPIVACAINE MONOHYDRATE; NAT. REGISTRATION NO/DATE: 212 IS 216 F 12 19960806; FIRST REGISTRATION: SE 12319 19950915
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Dow
Deloitte
Federal Trade Commission
Accenture
Healthtrust
Citi
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.